Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats

Shuanglin Hao, Keiko Mamiya, Osamu Takahata, Hiroshi Iwasaki, Marina Mata, David J. Fink

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Endomorphin-1 is a novel endogenous μ-opioid ligand. We investigated the antinociceptive interaction between endomorphin-1 and nifedipine, an L-type calcium channel blocker, microinjected into the midbrain ventrolateral periaqueductal gray (vPAG), using the spinally-organized tail-flick test and the supraspinally-organized tail-pressure test in rats. Sprague-Dawley rats were stereotaxically implanted with a guide cannula lowered into the vPAG. Microinjection of endomorphin-1 into the vPAG led to dose-related increases in antinociceptive responses in the tail-flick test and tail-pressure test. Pretreatment with the μ-opioid receptor-selective antagonist β-funaltrexamine blocked the antinociceptive effect of endomorphin-1. Pretreatment with β-funaltrexamine alone had no effect on the tail-flick latency and tail-pressure threshold. Microinjection of nifedipine alone into the vPAG did not produce an antinociceptive response in the tail-flick test and tail-pressure test. However, injection of nifedipine into the vPAG potentiated the antinociceptive effect of endomorphin-1, producing a significant leftward shift in the dose-response curve of endomorphin-1 in both the tail-flick and tail-pressure tests. This result shows that the potent antinociceptive effect of endomorphin-1 microinjected into the vPAG is mediated through the μ-opioid receptor and is potentiated by concomitant administration of nifedipine.

Original languageEnglish
Pages (from-to)1065-1071
Number of pages7
JournalAnesthesia and Analgesia
Volume96
Issue number4
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Periaqueductal Gray
Nifedipine
Tail
Pressure
Microinjections
endomorphin 1
L-Type Calcium Channels
Narcotic Antagonists
Calcium Channel Blockers
Opioid Receptors
Mesencephalon
Opioid Analgesics
Sprague Dawley Rats
Ligands

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats. / Hao, Shuanglin; Mamiya, Keiko; Takahata, Osamu; Iwasaki, Hiroshi; Mata, Marina; Fink, David J.

In: Anesthesia and Analgesia, Vol. 96, No. 4, 01.04.2003, p. 1065-1071.

Research output: Contribution to journalArticle

Hao, S, Mamiya, K, Takahata, O, Iwasaki, H, Mata, M & Fink, DJ 2003, 'Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats', Anesthesia and Analgesia, vol. 96, no. 4, pp. 1065-1071.
Hao, Shuanglin ; Mamiya, Keiko ; Takahata, Osamu ; Iwasaki, Hiroshi ; Mata, Marina ; Fink, David J. / Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats. In: Anesthesia and Analgesia. 2003 ; Vol. 96, No. 4. pp. 1065-1071.
@article{43da0205d77640539fdd9a423dfa5b0e,
title = "Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats",
abstract = "Endomorphin-1 is a novel endogenous μ-opioid ligand. We investigated the antinociceptive interaction between endomorphin-1 and nifedipine, an L-type calcium channel blocker, microinjected into the midbrain ventrolateral periaqueductal gray (vPAG), using the spinally-organized tail-flick test and the supraspinally-organized tail-pressure test in rats. Sprague-Dawley rats were stereotaxically implanted with a guide cannula lowered into the vPAG. Microinjection of endomorphin-1 into the vPAG led to dose-related increases in antinociceptive responses in the tail-flick test and tail-pressure test. Pretreatment with the μ-opioid receptor-selective antagonist β-funaltrexamine blocked the antinociceptive effect of endomorphin-1. Pretreatment with β-funaltrexamine alone had no effect on the tail-flick latency and tail-pressure threshold. Microinjection of nifedipine alone into the vPAG did not produce an antinociceptive response in the tail-flick test and tail-pressure test. However, injection of nifedipine into the vPAG potentiated the antinociceptive effect of endomorphin-1, producing a significant leftward shift in the dose-response curve of endomorphin-1 in both the tail-flick and tail-pressure tests. This result shows that the potent antinociceptive effect of endomorphin-1 microinjected into the vPAG is mediated through the μ-opioid receptor and is potentiated by concomitant administration of nifedipine.",
author = "Shuanglin Hao and Keiko Mamiya and Osamu Takahata and Hiroshi Iwasaki and Marina Mata and Fink, {David J.}",
year = "2003",
month = "4",
day = "1",
language = "English",
volume = "96",
pages = "1065--1071",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats

AU - Hao, Shuanglin

AU - Mamiya, Keiko

AU - Takahata, Osamu

AU - Iwasaki, Hiroshi

AU - Mata, Marina

AU - Fink, David J.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Endomorphin-1 is a novel endogenous μ-opioid ligand. We investigated the antinociceptive interaction between endomorphin-1 and nifedipine, an L-type calcium channel blocker, microinjected into the midbrain ventrolateral periaqueductal gray (vPAG), using the spinally-organized tail-flick test and the supraspinally-organized tail-pressure test in rats. Sprague-Dawley rats were stereotaxically implanted with a guide cannula lowered into the vPAG. Microinjection of endomorphin-1 into the vPAG led to dose-related increases in antinociceptive responses in the tail-flick test and tail-pressure test. Pretreatment with the μ-opioid receptor-selective antagonist β-funaltrexamine blocked the antinociceptive effect of endomorphin-1. Pretreatment with β-funaltrexamine alone had no effect on the tail-flick latency and tail-pressure threshold. Microinjection of nifedipine alone into the vPAG did not produce an antinociceptive response in the tail-flick test and tail-pressure test. However, injection of nifedipine into the vPAG potentiated the antinociceptive effect of endomorphin-1, producing a significant leftward shift in the dose-response curve of endomorphin-1 in both the tail-flick and tail-pressure tests. This result shows that the potent antinociceptive effect of endomorphin-1 microinjected into the vPAG is mediated through the μ-opioid receptor and is potentiated by concomitant administration of nifedipine.

AB - Endomorphin-1 is a novel endogenous μ-opioid ligand. We investigated the antinociceptive interaction between endomorphin-1 and nifedipine, an L-type calcium channel blocker, microinjected into the midbrain ventrolateral periaqueductal gray (vPAG), using the spinally-organized tail-flick test and the supraspinally-organized tail-pressure test in rats. Sprague-Dawley rats were stereotaxically implanted with a guide cannula lowered into the vPAG. Microinjection of endomorphin-1 into the vPAG led to dose-related increases in antinociceptive responses in the tail-flick test and tail-pressure test. Pretreatment with the μ-opioid receptor-selective antagonist β-funaltrexamine blocked the antinociceptive effect of endomorphin-1. Pretreatment with β-funaltrexamine alone had no effect on the tail-flick latency and tail-pressure threshold. Microinjection of nifedipine alone into the vPAG did not produce an antinociceptive response in the tail-flick test and tail-pressure test. However, injection of nifedipine into the vPAG potentiated the antinociceptive effect of endomorphin-1, producing a significant leftward shift in the dose-response curve of endomorphin-1 in both the tail-flick and tail-pressure tests. This result shows that the potent antinociceptive effect of endomorphin-1 microinjected into the vPAG is mediated through the μ-opioid receptor and is potentiated by concomitant administration of nifedipine.

UR - http://www.scopus.com/inward/record.url?scp=0037378618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037378618&partnerID=8YFLogxK

M3 - Article

C2 - 12651662

AN - SCOPUS:0037378618

VL - 96

SP - 1065

EP - 1071

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 4

ER -